oral therapeutic vaccine V3-X

{
  "id": "MLC-T-ONC-015703",
  "term": "oral therapeutic vaccine V3-X",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable therapeutic vaccine consisting of the tumor-associated antigen (TAA) oligosaccharide antigen sialyl Lewis A (CA19-9; sialylated Lewis A antigen; carbohydrate antigen 19-9; cancer antigen 19-9), with potential immunostimulating and antineoplastic activities. Upon oral administration, oral therapeutic vaccine V3-X induces a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells expressing CA19-9. CA19-9 is an antigen that is overexpressed in a variety of cancer cell types, and plays a key role in tumor cell survival and metastasis.",
  "synonyms": [
    "V3-X vaccine",
    "CA19-9 oral vaccine V3-X"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/oral-therapeutic-vaccine-v3-x/"
}